NEW YORK (GenomeWeb News) – The Center for Medical Technology Policy is funding a project that will develop guidance on evidence standards needed to evaluate next-generation sequencing-based tests for cancer diagnosis and treatment.

The CMTP-funded Green Park Collaborative is leading the effort via its Oncology Consortium.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.